2024 HCPCS Code J0652
Injection, levothyroxine sodium (hikma), not therapeutically equivalent to j0650, 10 mcg
TAGS: equivalent sodium levothyroxine therapeutically
Short Description | Inj, levothyroxine, hikma |
HCPCS Coverage Code | C - Carrier judgment |
HCPCS Action Code | C - Change in long description of procedure or modifier code |
HCPCS Action Effective Date | July 01, 2024 |
HCPCS Code Added Date | April 01, 2024 |
HCPCS Pricing Indicator Code | 51 - Drugs |
HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
HCPCS Coverage Issues Manual Reference Section Number | |
HCPCS Type Of Service Code | 1 - Medical care |
HCPCS Anesthesia Base Unit Quantity | 0 |
Check Similar HCPCS Codes
- J2272 - Inj, morphine (fresenius)
- J2274 - Inj morphine pf epid ithc
- J2275 - Morphine sulfate injection
- J2277 - Inj, motixafortide, 0.25 mg
- J2278 - Ziconotide injection
- J2280 - Inj, moxifloxacin 100 mg
- J2281 - Inj moxifloxacin (fres kabi)
- J2300 - Inj nalbuphine hydrochloride
- J2305 - Inj, nitroglycerin, 5 mg
- J2310 - Inj naloxone hydrochloride
- J2311 - Inj, naloxone hcl (zimhi)
- J2315 - Naltrexone, depot form
- J2320 - Nandrolone decanoate 50 mg
- J2323 - Natalizumab injection
- J2325 - Nesiritide injection
- J2326 - Inj, nusinersen, 0.1mg
- J2327 - Inj risankizumab-rzaa 1 mg
- J2329 - Inj ublituximab-xiiy, 1 mg
- J2350 - Injection, ocrelizumab, 1 mg
- J2353 - Octreotide injection, depot